(Q78130088)

English

Cardiovascular and renal effects of conivaptan hydrochloride (YM087), a vasopressin V1A and V2 receptor antagonist, in dogs with pacing-induced congestive heart failure

scientific article published on 01 July 1999

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10448882%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Cardiovascular and renal effects of conivaptan hydrochloride (YM087), a vasopressin V1A and V2 receptor antagonist, in dogs with pacing-induced congestive heart failure (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10448882%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

1 reference

based on heuristic

inferred from title

congestive heart failure

1 reference

based on heuristic

inferred from title

author name string

Yatsu T

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10448882%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Tomura Y

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10448882%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Tahara A

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10448882%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Wada K

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10448882%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Kusayama T

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10448882%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Tsukada J

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10448882%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Tokioka T

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10448882%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Uchida W

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10448882%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Inagaki O

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10448882%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Iizumi Y

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10448882%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Tanaka A

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10448882%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Honda K

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10448882%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

publication date

1 July 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10448882%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

European Journal of Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10448882%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

376

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10448882%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10448882%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

239-246

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10448882%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Rapid ventricular pacing in the dog: pathophysiologic studies of heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900379-9

7 January 2021

Vasoconstrictor role for vasopressin in experimental heart failure in the rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900379-9

7 January 2021

Current therapy of the failing heart

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900379-9

7 January 2021

Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900379-9

7 January 2021

Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: comparison with the renin-angiotensin system and the sympathetic nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900379-9

7 January 2021

Renal Response to Captopril in Severe Heart Failure: Role of Furosemide in Natriuresis and Reversal of Hyponatremia

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900379-9

7 January 2021

Neuroendocrine manifestations of congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900379-9

7 January 2021

Arginine vasopressin and the renal response to water loading in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900379-9

7 January 2021

Short-term effects of naloxone on hemodynamics and baroreflex function in conscious dogs with pacing-induced congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900379-9

7 January 2021

Effect of vasopressin antagonist on water excretion in inferior vena cava constriction

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900379-9

7 January 2021

Arginine vasopressin gene expression in chronic cardiac failure in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900379-9

7 January 2021

Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900379-9

7 January 2021

Alterations in serum sodium in relation to atrial natriuretic factor and other neuroendocrine variables in experimental pacing-induced heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900379-9

7 January 2021

Effects of a vasopressin antagonist with combined antipressor and antiantidiuretic activities in rats with left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900379-9

7 January 2021

Acute hemodynamic effect of a vascular antagonist of vasopressin in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900379-9

7 January 2021

Hormonal, global, and regional haemodynamic responses to a vascular antagonist of vasopressin in patients with congestive heart failure with and without hyponatraemia

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900379-9

7 January 2021

Therapeutic options in the management of chronic heart failure. Is there a drug of first choice?

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900379-9

7 January 2021

Pathophysiology of chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900379-9

7 January 2021

Treatment of chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900379-9

7 January 2021

Pathophysiology and current therapy of congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900379-9

7 January 2021

The renin-angiotensin-aldosterone system, antidiuretic hormone and sympathetic nerve activity in an experimental model of congestive heart failure in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900379-9

7 January 2021

Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (1)

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900379-9

7 January 2021

Relation between ventricular and myocyte remodeling with the development and regression of supraventricular tachycardia-induced cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900379-9

7 January 2021

Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900379-9

7 January 2021

Effect of YM087, a Potent Nonpeptide Vasopressin Antagonist, on Vasopressin-Induced Hyperplasia and Hypertrophy of Cultured Vascular Smooth-Muscle Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900379-9

7 January 2021

Pharmacological characterization of YM087, a potent, nonpeptide human vasopressin V1A and V2 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900379-9

7 January 2021

Pharmacological characterization of the human vasopressin receptor subtypes stably expressed in Chinese hamster ovary cells

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900379-9

7 January 2021

Effect of YM087, a potent nonpeptide vasopressin antagonist, on vasopressin-induced protein synthesis in neonatal rat cardiomyocyte

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900379-9

7 January 2021

Effects of MCI-154, a calcium sensitizer, on left ventricular systolic and diastolic function in pacing-induced heart failure in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900379-9

7 January 2021

Upregulation of aquaporin-2 water channel expression in chronic heart failure rat

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900379-9

7 January 2021

Pharmacological profile of YM087, a novel nonpeptide dual vasopressin V1A and V2 receptor antagonist, in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900379-9

7 January 2021

Effect of YM435, a Novel Dopamine DA1 Receptor Agonist, in a Canine Model of Acute Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900379-9

7 January 2021

Identifiers

10.1016/S0014-2999(99)00379-9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10448882%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10448882%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q78130088&oldid=2127404401"